US Patent Issued to ENCYT TECHNOLOGIES on July 14 for "Compositions and methods for the treatment of threatened respiratory failure caused by coronavirus infection and disease" (Canadian Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,418, issued on July 14, was assigned to ENCYT TECHNOLOGIES INC. (Membertou, Canada).

"Compositions and methods for the treatment of threatened respiratory failure caused by coronavirus infection and disease" was invented by Myron R. Szewczuk (Kingston, Canada) and William Warren Harless (Black Rock, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a coronavirus infection involves administering an inhibitor of the Neu1 sialidase-G protein-coupled receptor-Matrix metalloproteinase 9 (Neu1-GPCR-MMP9) signaling platform, in particular administering intravenously or by inhalation to a patient infected with COVID-19 and its varia...